Tanaka Misa, Arai Hidenori, Liu Ning, Nogaki Fumiaki, Nomura Keiko, Kasuno Kenji, Oida Emi, Kita Toru, Ono Takahiko
Division of Nephrology, Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kidney Int. 2005 Jun;67(6):2123-33. doi: 10.1111/j.1523-1755.2005.00317.x.
Fibrin deposition and mesangial cell proliferation are frequently observed in the active type of mesangioproliferative glomerulonephritis. Coagulation factors, such as factor V and factor Xa are colocalized with fibrin in the mesangial areas in active type of IgA nephropathy with mesangial cell proliferation. In this study, therefore, we studied the role of factor Xa and its receptor, protease-activated receptor 2 (PAR2) in mesangial cell proliferation and fibrin deposition, and examined ant-proliferative effects of a specific factor Xa inhibitor, DX-9065a, in cultured human mesangial cells.
To examine the effect of DX-9065a on the factor Xa-induced proliferation of cultured human mesangial cells, we measured thymidine incorporation and cell numbers. We also examined the effect of DX-9065a on extracellular regulated kinase (ERK) activation and fibrin production induced by factor Xa in human mesangial cells.
Factor Xa increased [(3)H]-thymidine incorporation and cell numbers in a dose-dependent manner in mesangial cells, which was inhibited by DX-9065a. DX-9065a also suppressed factor Xa-triggered fibrin deposition on mesangial cell surface. Factor Xa induced the activation of ERK in mesangial cells and this activation was also completely inhibited by DX-9065a, but not inhibited by PAR1 antagonist. Factor Xa-induced cell proliferation and ERK activation were inhibited by PD98059.
There results suggest that factor Xa can induce mesangial cell proliferation through the activation of ERK via PAR2 in mesangial cells and that PAR2 may play a crucial role in the cell proliferation induced by factor Xa. Our results implicate that DX-9065a may be a promising agent to regulate proliferation of mesangial cellss and inhibit the coagulation process in mesangium.
在系膜增生性肾小球肾炎的活动期,常可见纤维蛋白沉积和系膜细胞增殖。在伴有系膜细胞增殖的IgA肾病活动期,凝血因子如因子V和因子Xa与系膜区的纤维蛋白共定位。因此,在本研究中,我们研究了因子Xa及其受体蛋白酶激活受体2(PAR2)在系膜细胞增殖和纤维蛋白沉积中的作用,并检测了特异性因子Xa抑制剂DX - 9065a对培养的人系膜细胞的抗增殖作用。
为检测DX - 9065a对因子Xa诱导的培养人系膜细胞增殖的影响,我们检测了胸苷掺入量和细胞数量。我们还检测了DX - 9065a对人系膜细胞中因子Xa诱导的细胞外调节激酶(ERK)激活和纤维蛋白产生的影响。
因子Xa以剂量依赖性方式增加系膜细胞中[³H] - 胸苷掺入量和细胞数量,这一作用被DX - 9065a抑制。DX - 9065a还抑制因子Xa触发的系膜细胞表面纤维蛋白沉积。因子Xa诱导系膜细胞中ERK激活,这一激活也被DX - 9065a完全抑制,但不被PAR1拮抗剂抑制。因子Xa诱导的细胞增殖和ERK激活被PD98059抑制。
这些结果表明,因子Xa可通过系膜细胞中PAR2激活ERK来诱导系膜细胞增殖,且PAR2可能在因子Xa诱导的细胞增殖中起关键作用。我们的结果提示,DX - 9065a可能是一种有前景的药物,可调节系膜细胞增殖并抑制系膜中的凝血过程。